About Cantor Fitzgerald
Cantor Fitzgerald is an investment bank founded in 1945. It is primarily based in New York City, United States. As of Jun 2025, Cantor Fitzgerald has facilitated 100 deals, comprising 40 M&A deals and 60 funding rounds. It has facilitated 8 deals in the last 12 months. It primarily facilitates Business Acquisition and Seed deals for United States and Canada based companies. The deals facilitated are spread across a wide range of sectors from Mining to Life Sciences. Most recently, it facilitated the $7.31M Post IPO round of on Jun 12, 2025 and the acquisition of Thrive Skilled Pediatric Care by Aveanna on Apr 03, 2025. Apart from facilitating deals, Cantor Fitzgerald has also invested in 13 companies and acquired 4 companies till Jun 2025.
Key Metrics
Founded Year
1945
Location
New York City, United States
No. of Deals facilitated
100
No. of Deals facilitated in last 12 months
8
Top Deal Types
Post IPO, Business Acquisition
Top Locations of Deals
Top Sectors of Deals
Funding Rounds Facilitated
, &
M&A Facilitated
Team profile of Cantor Fitzgerald
Cantor Fitzgerald has a team of 388 membersÌý¾±²Ô³¦±ô³Ü»å¾±²Ô²µ 192 Partners and 119 Principals located in United States, United Kingdom and . Cantor Fitzgerald's team does not sit on the board of any company as of now.Here is a list of top team members in Cantor Fitzgerald:
Name | Designation | Location | Contact details |
|---|---|---|---|
Partner | New York City | ||
Partner | United States | ||
Partner | New York City | - | |
Partner | New York City | ||
Partner | Dublin | ||
Partner | New York City | ||
Partner | San Francisco | , | |
Partner | San Diego | ||
Partner | New York City | - | |
Partner | New York City | - | |
Partner | New York City |
Cantor Fitzgerald News
•
Benzinga•Jun 18, 2025•, Cantor Fitzgerald
•
Financial Post•Jun 16, 2025•, Cantor Fitzgerald
•
•
Mining Stock Education•Jun 13, 2025•, Cantor Fitzgerald
•
GlobeNewswire•Jun 13, 2025•Sprott Asset Management, Cantor Fitzgerald, Virtu, BMO Capital Markets and 2 others
•
•
•
•
PR Newswire•Jun 06, 2025•Trevi Therapeutics, Morgan Stanley, Leerink Partners, Stifel and 1 other
•
